265 related articles for article (PubMed ID: 36401300)
1. Towards elucidating disease-relevant states of neurons and glia by CRISPR-based functional genomics.
Leng K; Kampmann M
Genome Med; 2022 Nov; 14(1):130. PubMed ID: 36401300
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-based functional genomics for neurological disease.
Kampmann M
Nat Rev Neurol; 2020 Sep; 16(9):465-480. PubMed ID: 32641861
[TBL] [Abstract][Full Text] [Related]
3. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
Zhang Y; Karakikes I
Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-based functional genomics screening in human-pluripotent-stem-cell-derived cell types.
Li K; Ouyang M; Zhan J; Tian R
Cell Genom; 2023 May; 3(5):100300. PubMed ID: 37228745
[TBL] [Abstract][Full Text] [Related]
5. A CRISPR view of hematopoietic stem cells: Moving innovative bioengineering into the clinic.
Worthington AK; Forsberg EC
Am J Hematol; 2022 Sep; 97(9):1226-1235. PubMed ID: 35560111
[TBL] [Abstract][Full Text] [Related]
6. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
Taylor J; Woodcock S
J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-engineered genome editing for the next generation neurological disease modeling.
Feng W; Liu HK; Kawauchi D
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():459-467. PubMed ID: 28536069
[TBL] [Abstract][Full Text] [Related]
8. Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR.
Espino-Saldaña AE; Rodríguez-Ortiz R; Pereida-Jaramillo E; Martínez-Torres A
Curr Neuropharmacol; 2020; 18(2):136-152. PubMed ID: 31573887
[TBL] [Abstract][Full Text] [Related]
9. A new era in functional genomics screens.
Przybyla L; Gilbert LA
Nat Rev Genet; 2022 Feb; 23(2):89-103. PubMed ID: 34545248
[TBL] [Abstract][Full Text] [Related]
10. Functional interrogation of autoimmune disease genetics using CRISPR/Cas9 technologies and massively parallel reporter assays.
Ding J; Frantzeskos A; Orozco G
Semin Immunopathol; 2022 Jan; 44(1):137-147. PubMed ID: 34508276
[TBL] [Abstract][Full Text] [Related]
11. Is Pooled CRISPR-Screening the Dawn of a New Era for Functional Genomics.
Yao J; Dai HL
Adv Exp Med Biol; 2018; 1068():171-176. PubMed ID: 29943304
[TBL] [Abstract][Full Text] [Related]
12. Application of CRISPR-Cas9 Screening Technologies to Study Mitochondrial Biology in Healthy and Disease States.
Sharon D; Chan SM
Adv Exp Med Biol; 2019; 1158():269-277. PubMed ID: 31452146
[TBL] [Abstract][Full Text] [Related]
13. Advances in Engineering the Fly Genome with the CRISPR-Cas System.
Bier E; Harrison MM; O'Connor-Giles KM; Wildonger J
Genetics; 2018 Jan; 208(1):1-18. PubMed ID: 29301946
[No Abstract] [Full Text] [Related]
14. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
15. CRISPR screens for functional interrogation of immunity.
Shi H; Doench JG; Chi H
Nat Rev Immunol; 2023 Jun; 23(6):363-380. PubMed ID: 36481809
[TBL] [Abstract][Full Text] [Related]
16. Advances in Genomics for Drug Development.
Spreafico R; Soriaga LB; Grosse J; Virgin HW; Telenti A
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32824125
[TBL] [Abstract][Full Text] [Related]
17. High-throughput CRISPRi and CRISPRa technologies in 3D genome regulation for neuropsychiatric diseases.
Jones IR; Ren X; Shen Y
Hum Mol Genet; 2022 Oct; 31(R1):R47-R53. PubMed ID: 35972825
[TBL] [Abstract][Full Text] [Related]
18. Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice.
Zhou H; Su J; Hu X; Zhou C; Li H; Chen Z; Xiao Q; Wang B; Wu W; Sun Y; Zhou Y; Tang C; Liu F; Wang L; Feng C; Liu M; Li S; Zhang Y; Xu H; Yao H; Shi L; Yang H
Cell; 2020 Apr; 181(3):590-603.e16. PubMed ID: 32272060
[TBL] [Abstract][Full Text] [Related]
19. Advances in therapeutic application of CRISPR-Cas9.
Sun J; Wang J; Zheng D; Hu X
Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases.
Singh DD; Hawkins RD; Lahesmaa R; Tripathi SK
Semin Cell Dev Biol; 2019 Dec; 96():32-43. PubMed ID: 31112800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
